Literature DB >> 5009614

Remission of psoriasis vulgaris from the use of nerve-blocking agents.

H H Perlman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5009614     DOI： 10.1001/archderm.1972.01620040088028

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  7 in total

1.  Linear psoriasis following the typical distribution of the sciatic nerve.

Authors:  Marco Galluzzo; Marina Talamonti; Alessandro Di Stefani; Sergio Chimenti
Journal:  J Dermatol Case Rep       Date:  2015-03-31

Review 2.  Calcitonin gene-related peptide: key regulator of cutaneous immunity.

Authors:  R D Granstein; J A Wagner; L L Stohl; W Ding
Journal:  Acta Physiol (Oxf)       Date:  2015-01-05       Impact factor: 6.311

Review 3.  Altered manifestations of skin disease at sites affected by neurological deficit.

Authors:  E Azimi; E A Lerner; S B Elmariah
Journal:  Br J Dermatol       Date:  2015-02-25       Impact factor: 9.302

Review 4.  Nerve-derived transmitters including peptides influence cutaneous immunology.

Authors:  Elizabeth N Madva; Richard D Granstein
Journal:  Brain Behav Immun       Date:  2013-03-18       Impact factor: 7.217

5.  Cutaneous denervation of psoriasiform mouse skin improves acanthosis and inflammation in a sensory neuropeptide-dependent manner.

Authors:  Stephen M Ostrowski; Abdelmadjid Belkadi; Candace M Loyd; Doina Diaconu; Nicole L Ward
Journal:  J Invest Dermatol       Date:  2011-04-07       Impact factor: 8.551

6.  Botulinum neurotoxin A decreases infiltrating cutaneous lymphocytes and improves acanthosis in the KC-Tie2 mouse model.

Authors:  Nicole L Ward; Kevin D Kavlick; Doina Diaconu; Sean M Dawes; Kellie A Michaels; Erin Gilbert
Journal:  J Invest Dermatol       Date:  2012-03-15       Impact factor: 8.551

7.  Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach.

Authors:  Máté Manczinger; Lajos Kemény
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.